Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Hypophosphatasia (HPP)
Interventions
BIOLOGICAL

asfotase alfa

Trial Locations (10)

19803

Alfred I. duPont Hospital for Children, Wilmington

37232

Vanderbilt Children's Hospital, Nashville

54301

St. Vincent Hospital, Green Bay

65804

St. John's Hospital, Springfield

68114

University of Nebraska Medical Center, Munroe-Meyer Institute, Omaha

72202

Arkansas Children's Hospital, Little Rock

R3A 1S1

The University of Manitoba Health Sciences Centre, Winnipeg

Unknown

Tawam-John Hopkins Hospital, Al Ain City

Royal Belfast Hospital for Sick Children, Belfast

S10 2TH

Sheffield Children's Hospital, Sheffield

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY